Page 2 - Alex Marson News Today

/PRNewswire/ -- Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy (PICI), the leading network of immuno-oncology expertise...

/PRNewswire/ -- GenScript USA Inc., the worlds leading life-science research tools and services provider, is collaborating with researchers at the...

The recent announcement, delivered at the American Society of Gene & Cell Therapy’s (ASGCT) 25th annual meeting, cements GenScript’s position as the leading provider of non-viral homology-directed repair (HDR) template solutions for immune-cell engineering.

T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors.

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

/PRNewswire/ -- A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications....

The new immune gene networks have implications for developing immunotherapies and understanding autoimmune diseases.

Using new technologies to study thousands of genes simultaneously within immune cells, researchers at Gladstone Institutes, UC San Francisco (UCSF), and Stanford School of Medicine have created the most detailed map yet of how complex networks of genes function together.

When faced with a formidable foe for months on end, the immune system's T cells begin to tire. Whether fighting a cancer or a chronic infection, they become less effective over time, a phenomenon dubbed "T cell exhaustion" by scientists.